» Articles » PMID: 38556858

MicroRNA Expression As a Prognostic Biomarker of Tongue Squamous Cell Carcinoma (TSCC): a Systematic Review and Meta-analysis

Overview
Journal BMC Oral Health
Publisher Biomed Central
Specialty Dentistry
Date 2024 Apr 1
PMID 38556858
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Recent studies have indicated that microRNA (miRNA) expression in tumour tissues has prognostic significance in Tongue squamous cell carcinoma (TSCC) patients. This study explored the possible prognostic value of miRNAs for TSCC based on published research.

Methods: A comprehensive literature search of multiple databases was conducted according to predefined eligibility criteria. Data were extracted from the included studies by two researchers, and HR results were determined based on Kaplan‒Meier curves according to the Tierney method. The Newcastle‒Ottawa Scale (NOS) and GRADE (Grading of Recommendations Assessment, Development, and Evaluation) pro-GDT were applied to assess the quality of all studies. Publication bias was estimated by funnel plot, Egger's rank correlation test and sensitivity analysis.

Results: Eleven studies (891patients) were included, of which 6 reported up-regulated miRNAs and 7 mentioned down-regulated miRNAs. The pooled hazard ratio (HR) from the prognostic indicator overall survival (OS) was 1.34 (1.25-1.44), p < 0.00001, indicating a significant difference in miRNA expression between TSCC patients with better or worse prognosis.

Conclusion: MiRNAs may have high prognostic value and could be used as prognostic biomarkers of TSCC.

References
1.
Zheng G, Li N, Jia X, Peng C, Luo L, Deng Y . MYCN-mediated miR-21 overexpression enhances chemo-resistance via targeting CADM1 in tongue cancer. J Mol Med (Berl). 2016; 94(10):1129-1141. DOI: 10.1007/s00109-016-1417-0. View

2.
Li H, Liu Y, Shen Z, Gan X, Han J, Liu Y . Downregulation of MACC1 inhibits invasion, migration and proliferation, attenuates cisplatin resistance and induces apoptosis in tongue squamous cell carcinoma. Oncol Rep. 2014; 33(2):651-60. DOI: 10.3892/or.2014.3612. View

3.
Ding L, Fu Y, Zhu N, Zhao M, Ding Z, Zhang X . OXTR stroma fibroblasts control the invasion pattern of oral squamous cell carcinoma via ERK5 signaling. Nat Commun. 2022; 13(1):5124. PMC: 9433374. DOI: 10.1038/s41467-022-32787-y. View

4.
Supic G, Zeljic K, Divac Rankov A, Kozomara R, Nikolic A, Radojkovic D . miR-183 and miR-21 expression as biomarkers of progression and survival in tongue carcinoma patients. Clin Oral Investig. 2017; 22(1):401-409. DOI: 10.1007/s00784-017-2126-y. View

5.
Page M, McKenzie J, Bossuyt P, Boutron I, Hoffmann T, Mulrow C . The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021; 372:n71. PMC: 8005924. DOI: 10.1136/bmj.n71. View